周二，欧洲股市在圣诞节前夕缩短的交易时段收高。斯托克600指数上涨0.2%，科技股领涨，此前美国同行周一表现强劲。伦敦富时100指数和法国CAC 40指数也收涨。诺和诺德股价飙升5.7%，从上周CagriSema减肥药试验结果令人失望后的暴跌中恢复过来。在监管机构反馈后，阿斯利康撤回了其在欧盟的癌症治疗申请，股价收盘上涨0.1%。矿业股推动以英美资源集团为首的斯托克600指数上涨2%，尽管智利因涉嫌环境违规而面临170亿美元的潜在罚款。有关中国计划在2025年创纪录发行国债的报道支持了市场情绪。另一方面，由于年终延迟，Vistry Group下调了利润预测，下跌了16%，而瑞典博彩公司Evolution在监管审查中继续下滑。

European markets ended higher on Tuesday in a shortened session ahead of Christmas Eve. The Stoxx 600 rose 0.2%, with tech stocks leading gains after a strong performance by US peers on Monday. London's FTSE 100 and France's CAC 40 also closed in positive territory. Novo Nordisk surged 5.7%, recovering from last week’s slump following disappointing trial results for its CagriSema weight-loss drug. AstraZeneca withdrew its EU application for a lung cancer treatment after feedback from regulators, with shares closing up 0.1%. Mining stocks boosted the Stoxx 600, led by Anglo American, up 2%, despite facing $17 billion in potential fines in Chile over alleged environmental violations. Reports of China’s planned record treasury bond issuance in 2025 supported sentiment. At the other end, Vistry Group dropped 16% after revising profit forecasts downward due to year-end delays, while Swedish gambling firm Evolution continued its slide amid regulatory scrutiny.

欧洲斯托克600指数微涨0.2%，德国等主要市场关闭，伦敦和巴黎等其他市场将提前关闭。法国CAC 40表现优异，总理弗朗索瓦·贝鲁承诺将该国的预算赤字削减至近5%。科技股领涨，周一美国科技股表现强劲。制药巨头诺和诺德也提振了该指数，在从上周因其减肥药CagriSema的试验结果令人失望而引发的抛售中复苏后，该指数飙升5.7%。尽管有这些涨幅，但欧洲股市表现不如美国股市，受到法国和德国经济增长疲软和政治不确定性的拖累。斯托克600指数自9月触及高点以来下跌了4%以上，有望创下两年来最大的季度跌幅。

Europe's Stoxx 600 index edged up 0.2%, with major markets like Germany closed and others, including London and Paris, set for early closures. France’s CAC 40 outperformed as Prime Minister François Bayrou pledged to cut the country's budget deficit to near 5%. Tech stocks led gains, supported by a strong session for US tech shares on Monday. Pharmaceuticals giant Novo Nordisk also boosted the index, surging 5.7% after recovering from last week’s sell-off linked to disappointing trial results for its weight-loss drug, CagriSema. Despite these gains, European stocks have underperformed US markets, weighed down by weak economic growth and political uncertainty in France and Germany. The Stoxx 600 is down over 4% since hitting a high in September, on track for its biggest quarterly loss in two years.

欧洲股市周二开盘走低，圣诞节前交易疲软。预计交易量将很小，许多投资者已经处于假期模式。尽管如此，市场仍关注欧洲央行和美联储的货币政策前景，以及美国关税对欧洲制造业需求的影响。在企业方面，Stellantis的FCA美国子公司同意支付420万美元，以解决加利福尼亚州对过量排放的调查，这可能会对这家意大利汽车制造商的股票造成压力。经济新闻方面，荷兰第三季度GDP增长率为0.8%，低于上一季度1.1%的两年高点。

European equity markets were set to open lower on Tuesday amid subdued trading ahead of the Christmas holidays. Trading volumes are expected to be light, with many investors already in holiday mode. Still, markets remained focused on the monetary policy outlooks of the ECB and the Fed, as well as the impact of US tariffs on European manufacturing demand. On the corporate front, Stellantis' FCA US unit agreed to pay $4.2 million to settle a California investigation into excess emissions, which could weigh on the Italian automaker’s stock. In economic news, Dutch GDP growth for Q3 was confirmed at 0.8%, down from a two-year high of 1.1% in the previous quarter.

由于圣诞节假期，欧洲股市周一收盘涨跌互现，本周交易量稀少，市场继续评估美联储利率的前景以及美国关税对欧洲制造业需求的影响。欧元区STOXX 50指数下跌0.3%，收于4850点，但更广泛的泛欧STOXX 600指数上涨0.1%，收于503点。关于欧洲央行的政策，央行行长克里斯蒂娜·拉加德周一表示，欧元区“非常接近”实现央行的中期通胀目标。德国汽车巨头是当天跌幅最大的公司之一，梅赛德斯-奔驰、宝马和大众汽车的跌幅在2%至0.8%之间。反过来，Prosus和Adyen下跌1.5%，对科技板块构成压力。在STOXX 50指数之外，制药巨头诺和诺德在其肥胖药物Caglisema的测试结果令人失望后，上涨了5%，以弥补周五20%的跌幅，推动STOXX 600指数小幅上涨。

European stocks closed mixed on Monday at the start of a week of thin trading due to the Christmas holidays, as markets continued to assess the outlook of rates from the Fed and the impact that tariffs from the US would have on European manufacturing demand. The Eurozone’s STOXX 50 fell 0.3% to close at 4,850, but the broader, pan-European STOXX 600 gained 0.1% to close at 503. Regarding the ECB’s policy, the central bank’s President Christine Lagarde commented on Monday that the Eurozone is "very close" to achieving the central bank's medium-term inflation target. German auto giants were among the sharpest losers of the session, with Mercedes Benz, BMW, and Volkswagen sinking between 2% and 0.8%. In turn, Prosus and Adyen lost 1.5% to weigh on the tech sector. Outside the STOXX 50, pharmaceutical giant Novo Nordisk added 5% to trim the 20% plunge on Friday after disappointing test results for its obesity drug Cagrisema, driving the STOXX 600 to close slightly higher.